Loading insider details...
Beta
Latest Form 4 (Jul 10, 2026): Grant/Award of 7,500 MCRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 10, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 7,500 | n/a |
| Mar 6, 2026 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 22,500 | n/a |
| Oct 15, 2025 | ESSA Pharma Inc. (EPIX) | Disposition to Issuer | 2,881 | n/a |
| Feb 11, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 650,000 | n/a |
| Jul 1, 2024 | Carisma Therapeutics Inc. (CARM) | Grant/Award | 38,700 | n/a |
| Mar 28, 2024 | ESSA Pharma Inc. (EPIX) | Grant/Award | 50,000 | n/a |
| Mar 27, 2024 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 700,000 | n/a |
| Nov 8, 2023 | Evelo Biosciences, Inc. (EVLO) | Exercise/Conversion | 6,500 | n/a |
| Nov 3, 2023 | Evelo Biosciences, Inc. (EVLO) | Exercise/Conversion | 12,500 | n/a |
| Sep 13, 2023 | Evelo Biosciences, Inc. (EVLO) | Grant/Award | 37,500 | n/a |